These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8105680)

  • 1. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
    Schoonjans R; Mast A; Van den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
    Am J Gastroenterol; 1993 Oct; 88(10):1759-63. PubMed ID: 8105680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
    Schoonjans R; Mast A; Van Den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
    Am J Gastroenterol; 1993 Sep; 88(9):1416-20. PubMed ID: 8103282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL; Ghezail M; Chertok P; Blotman F
    Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity after treatment with sulfasalazine.
    Haines JD
    Postgrad Med; 1986 May; 79(6):193-4, 197-8. PubMed ID: 2871549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases.
    Besnard M; Debray D; Durand P; Cézard JP; Navarro J
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):119-20. PubMed ID: 9443132
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of salicylazosulfapyridine: a case report and review of the literature.
    Gulley RM; Mirza A; Kelly CE
    Am J Gastroenterol; 1979 Nov; 72(5):561-4. PubMed ID: 43669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity.
    Sotolongo RP; Neefe LI; Rudzki C; Ishak KG
    Gastroenterology; 1978 Jul; 75(1):95-9. PubMed ID: 45581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.
    Mihas AA; Goldenberg DJ; Slaughter RL
    JAMA; 1978 Jun; 239(24):2590-1. PubMed ID: 26816
    [No Abstract]   [Full Text] [Related]  

  • 9. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfasalazine allergy: fever, skin rash, hepatitis and T-lymphocytes].
    Gyssens IC; de Bock RF; Peetermans ME
    Ned Tijdschr Geneeskd; 1989 Aug; 133(32):1608-10. PubMed ID: 2571950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.
    Carr-Locke DL
    Am J Gastroenterol; 1982 Sep; 77(9):614-6. PubMed ID: 6126117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine.
    Hautekeete ML; Bourgeois N; Potvin P; Duville L; Reynaert H; Devis G; Adler M; Klöppel G
    Gastroenterology; 1992 Dec; 103(6):1925-7. PubMed ID: 1360436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomembranous colitis. A complication of sulfasalazine therapy in a patient with Crohn's colitis.
    Pokorney BH; Nichols TW
    Am J Gastroenterol; 1981 Oct; 76(4):374-6. PubMed ID: 6119900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fatal hepatitis during sulfasalazine treatment].
    Larcan A; Lambert H; Janot C; Perarnaud J; Delorme N; Tonnel F
    Therapie; 1982; 37(3):315-9. PubMed ID: 6127817
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia.
    Gremse DA; Bancroft J; Moyer MS
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):261-3. PubMed ID: 2572687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug hypersensitivity syndrome associated with a primary HHV6 infection].
    Debarbieux S; Deroo-Berger MC; Grande S; Najioullah F; Kanitakis J; Faure M; Claudy A
    Ann Dermatol Venereol; 2006 Feb; 133(2):145-7. PubMed ID: 16508598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
    Ribe J; Benkov KJ; Thung SN; Shen SC; LeLeiko NS
    Am J Gastroenterol; 1986 Mar; 81(3):205-8. PubMed ID: 2869683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.